Graham Capital Management, L.P. Novartis Ag Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Novartis Ag stock. As of the latest transaction made, Graham Capital Management, L.P. holds 62,225 shares of NVS stock, worth $7.22 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
62,225
Previous 21,683
186.98%
Holding current value
$7.22 Million
Previous $2.1 Million
215.88%
% of portfolio
0.21%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.42 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.41 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$860 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$859 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$689 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...